Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities Only

This study has been completed.

Sponsors and Collaborators:	West Park Healthcare Centre University of Toronto Hamilton Health Sciences Ontario Ministry of Health and Long Term Care
Information provided by:	West Park Healthcare Centre
ClinicalTrials.gov Identifier:	NCT00546299

Purpose

Several studies have described the use of supplemental oxygen during exertion or activities of daily living (ambulatory oxygen) in study populations that have different characteristics. This report, based on specialized randomized controlled trials, characterizes ambulatory gas usage among patients with COPD who experience low oxygen levels during activities.

Condition	Intervention
Chronic Obstructive Pulmonary Disease	Drug: oxygen

MedlinePlus related topics: COPD (Chronic Obstructive Pulmonary Disease) Gas

Drug Information available for: Benzocaine

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Crossover Assignment, Efficacy Study
Official Title:	Ambulatory Gas Usage in Patients With COPD and Exertional Hypoxemia

Further study details as provided by West Park Healthcare Centre:

Primary Outcome Measures:

gas usage [ Time Frame: 2 ]

Enrollment:	27
Study Start Date:	February 2003
Study Completion Date:	December 2005

Intervention Details:

cylinder and concentrator, dosage to maintain SpO2 above 92%, used during exertion

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Diagnosis of COPD
dyspnea limiting daily activities
desaturation less than or equal to 88% for 2 continuous minutes during a room air six-minute walk test

Exclusion Criteria:

less than or equal to 18 years old
those who met criteria for mortality reduction with long-term oxygen
those who received oxygen for palliative care or isolated nocturnal hypoxemia
those unable to complete the questionnaires or provide informed consent

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00546299

Sponsors and Collaborators

West Park Healthcare Centre

University of Toronto

Hamilton Health Sciences

Ontario Ministry of Health and Long Term Care

Investigators

Study Director:

Roger Goldstein, MD

Respiratory Rehabilitation, West Park Healthcare Centre

More Information

Study ID Numbers:	8-42361
Study First Received:	October 17, 2007
Last Updated:	October 17, 2007
ClinicalTrials.gov Identifier:	NCT00546299
Health Authority:	Canada: Ministry of Health & Long Term Care, Ontario

Keywords provided by West Park Healthcare Centre:

Ambulatory oxygen therapy
COPD
exertional hypoxemia

Study placed in the following topic categories:

Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases
Benzocaine
Pulmonary Disease, Chronic Obstructive

ClinicalTrials.gov processed this record on January 16, 2009